AzTrials
AzTrials

Old Age; AtrophyFITFOODNCT05413616

The Effect of a Combined Personalized Nutritional Intervention and a Personalized Graded Activity Functional Training Program on Physical Performance in Hospitalized Older Patients, Compared to Usual Care

A study testing FITFOOD lifestyle intervention in people with Old Age; Atrophy, run by Radboud University Medical Center at 1 site in Netherlands.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This project aims to improve physical performance in older patients, by offering a personalized combined nutritional intervention with a physical activity training program. The intervention starts at hospital admittance and is continued after discharge in the home care setting, supported by an e-health application. Read more about this study

Who is it for?
Ages 65 years and older
Conditions the study is for
Old Age; Atrophy
What is being tested?
FITFOOD lifestyle intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
136 participants
Where
1 siteNetherlands
Study dates
4 Jul 2022to 1 Jul 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • No healthy volunteers
  • Older adult

Who may be able to join

  • Aged ≥65 years
  • Living within the Nijmegen area (within 40km)
  • Admitted to clinical ward of Radboudumc or CWZ
  • Understanding and speaking of the Dutch language
  • Mentally competent
  • Signed informed consent

Who cannot join

  • Complete use of tube feeding or parenteral nutrition
  • Renal insufficiency (MDRD-GFR < 30ml/min)

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Netherlands1 site, 1 recruiting
  • Sabien van Exter

    Nijmegen, Gelderland, 6531DK

    Sabien van Exter, MSc, 0631015162, sabien.vanexter@radboudumc.nl

    Manon van den Berg, MSc, PhD, 0243614760, manon.vandenberg@radboudumc.nl

    Recruiting

Other trials in Netherlands

About this study

Official title: The Effect of a Combined Personalized Nutritional Intervention and a Personalized Graded Activity Functional Training Program on Physical Performance in Hospitalized Older Patients, Compared to Usual Care: A Randomized Clinical Trial

This project aims to improve physical performance in older patients, by offering a personalized combined nutritional intervention with a physical activity training program. The intervention starts at hospital admittance and is continued after discharge in the home care setting, supported by an e-health application.

Read the detailed description

Rationale: The older hospitalized population is growing and specifically at risk for decreased muscle mass and physical functioning and has a negative influence on activities of daily living, independence, quality of life, re-admissions, and nursing home placement. Current knowledge shows that a physical activity training programs consisting of tailored resistance and endurance exercise can improve muscle mass in healthy elderly. Nutritional interventions in conjunction with physical activity based on individual protein requirements, high quality protein and timing of protein intake can further stimulate muscle protein synthesis. The effect of a combined nutritional intervention with physical activity in healthy individuals and athletes has been studied before, but not in older hospitalized patients. A personalized combined physical activity program and a nutritional intervention could be a solution and is an exciting emerging field of research with the potential to dramatically improve patient outcomes.

The average hospital admittance is 4 to 5 days in which the prevention of the decline in muscle mass and physical performance can be initiated but not improved. Thus, the translation of a prolonged combined intervention to home care is essential. To support the combined personalized nutritional intervention and physical exercise intervention during hospitalization and home care, an eHealth application for and with older patients can be beneficial.

Objective: This project aims to improve physical performance in older patients, by offering a personalized combined nutritional intervention with a physical activity training program. The intervention starts at hospital admittance, and is continued after discharge in the home care setting, supported by an e-health application.

Study design: The study will be performed as a randomized clinical trial. Study population: The study population hospitalized adult patients of ≥65 years, living in the Nijmegen area within the Radboud University Medical Centre.

Intervention: One group receives a personalized nutritional intervention by a dietician combines with a functional training program by physical therapists. The nutritional intervention focuses on adequate protein intake, type, and timing of protein. The exercise program will make use of goal setting throughout the intervention period to optimize the training effect . The control group will receive usual care.

Study parameters: The primary study outcome is based on the difference in change in physical performance between baseline and after 3 months of intervention of the intervention and the control group (usual care). This will be analyzed using multilevel mixed model corrected by potential confounders, measured by the Timed up \& Go test (TUG), a sensitive tool to measure physical performance in elderly.

Secondary: As a secondary outcome, the effect on short physical performance battery, muscle strength, muscle mass, nutritional status, movement, independence, quality of life, clinical outcomes and cost-effectiveness will be studied.

Nature and extent of the burden and risks associated with participation, benefit, and group relatedness: Study measurements are non-invasive. This study will not confer any no additional risks. The intervention will start at hospital admittance and will be continued after discharge in the home setting by a dietician and physiotherapist in their nearby home, which keeps the burden for the patient relatively low and is an extra service for the patient. Protein supplementation will be delivered within the save amounts. Possible serious reactions to the intervention will be noted as SAE's.

Being tested
FITFOOD lifestyle intervention
Keywords
nutrition, protein, exercise, sarcopenia, older people, vitamin D
Medical subject headings
Atrophy, Motor Activity, Sarcopenia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • FITFOOD lifestyle interventionBehavioural

    Lifestyle intervention with a nutritional and exercise component.

Study groups in NCT05413616
Study groupRoleWhat they receive
Standard careNo interventionNot described
FITFOOD lifestyle interventionExperimentalLifestyle intervention consisting of both a nutritional and exercise intervention.
Receives: Behavioral: FITFOOD lifestyle intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Timed Up & Go

    TUG

    Measured: Baseline, 1 day before hospital release, 4 weeks after baseline, 12 weeks after baseline, 24 weeks after baseline.

Secondary outcomes (15)
  1. Change in Short Physical Performance Battery

    Short Physical Performance Battery (scale: 0-12, a high score indicates no disability, a low score means disabilities may be present or developing).

    Measured: Baseline, 1 day before hospital release, 4 weeks after baseline, 12 weeks after baseline, 24 weeks after baseline.

  2. Change in muscle strength

    Handgrip strength

    Measured: Baseline, 1 day before hospital release, 12 weeks after baseline, 24 weeks after baseline.

  3. Change in muscle mass

    BIA

    Measured: Baseline, 1 day before hospital release, 12 weeks after baseline, 24 weeks after baseline.

  4. Change in nutritional status

    Patient-Generated Subjective Global Assessment (PG-SGA). Scale: 0-49 (low score: no intervention needed. Score>9: serious indication for intervention)

    Measured: Baseline, 1 day before hospital release, 4 weeks after baseline, 12 weeks after baseline, 24 weeks after baseline.

  5. Change in nutritional intake (energy, protein).

    Food diary.

    Measured: Baseline, 1 day before hospital release, 4 weeks after baseline, 12 weeks after baseline, 24 weeks after baseline.

  6. Change in movement according to actometer

    Activ8 measurement will assess movement during 1 week for each measurement point

    Measured: Baseline, 1 day before hospital release, 12 weeks after baseline, 24 weeks after baseline.

  7. Change in activities of daily living

    LLFDI-CAT (Late-Life Function and Disability Instrument Computer Adaptive Test). LLFDI-CAT scores are transformed to a scale with mean = 50 and standard deviation =10.

    Lower scores correspond to more limitation.

    Measured: Baseline, 1 day before hospital release, 12 weeks after baseline, 24 weeks after baseline.

  8. Change in quality of life

    EQ-5D-5L (EuroQol 5-level five-dimensional questionnaire). Scores 1-5 where 1 is good and 5 indicates issues or problems.

    Measured: Baseline, 1 day before hospital release, 12 weeks after baseline, 24 weeks after baseline.

  9. Clinical outcomes: length of hospital stay

    Length of hospital stay

    Measured: 24 weeks after baseline

  10. Clinical outcomes: re-admission

    Re-admission

    Measured: 24 weeks after baseline

  11. Clinical outcomes: complications

    Complications

    Measured: 24 weeks after baseline

  12. Clinical outcomes: mortality

    Mortality

    Measured: 24 weeks after baseline

  13. Medical consumption

    iMCQ: iMTA Medical Consumption Questionnaire. Medical consumption will be measured using iMCQ and costs are calculated using Dutch reference values.

    Measured: Baseline

  14. Medical consumption

    iMCQ: iMTA Medical Consumption Questionnaire. Medical consumption will be measured using iMCQ and costs are calculated using Dutch reference values.

    Measured: 12 weeks after baseline, 24 weeks after baseline

  15. Risk for Sarcopenia

    SARC-F: Strength, Assistance with walking, Rise from a chair, Climb stairs (scored 0-1-, higher score means higher risk for sarcopenia) and Falls

    Measured: Baseline, 1 day before hospital release, 4 weeks after baseline, 12 weeks after baseline, 24 weeks after baseline.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Jun 2022
  2. Study start4 Jul 2022
  3. Primary completion1 Nov 2026 (estimated)
  4. Study completion1 Jul 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
136 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05413616
Sponsor's protocol ID
2020-6664
Acronym
FITFOOD
Status last verified
Jul 2025
First submitted
19 May 2022
Last updated
24 Jul 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • van Exter SH, Koenders N, van der Wees PJ, Drenth JPH, van den Berg MGA. Lessons learned from a combined, personalized lifestyle intervention in hospitalized patients at risk for sarcopenia: a feasibility study. Disabil Rehabil. 2025 Jul;47(14):3679-3686. doi: 10.1080/09638288.2024.2426685. Epub 2024 Nov 12.

    PubMed 39530465

Questions about this trial

What is this clinical trial studying?

A study testing FITFOOD lifestyle intervention in people with Old Age; Atrophy, run by Radboud University Medical Center at 1 site in Netherlands.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 24 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Netherlands. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Timed Up & Go (time frame: Baseline, 1 day before hospital release, 4 weeks after baseline, 12 weeks after baseline, 24 weeks after baseline.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05413616, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Jul 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in